Substituted pyrimido[1,6-a]pyrimidines as Lp-PLA2 inhibitors
US9273054B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2012 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Nov 8, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.